Log In
Saturday 24th August 2019

New clot drug for heart patients

24th May 2012

The National Institute for Health and Clinical Excellence (NICE) has recommended the use of a new type of blood thinning drug for heart patients to cut their risk of stroke.

It says patients with atrial fibrillation (AF), an erratic and sometimes fast heartbeat, can now have rivaroxiban instead of the existing drug warfarin and follows NICE’s recent approval of another drug - dabigatran - for AF. The move has been welcomed by heart experts who say warfarin can be problematic.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019